Evidence supporting the use of: Apocynin
For the health condition: Chronic Obstructive Pulmonary Disorder

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Apocynin is a naturally occurring compound derived from the root of Picrorhiza kurroa and has been studied for its inhibitory effects on NADPH oxidase, an enzyme complex implicated in the generation of reactive oxygen species (ROS). Excessive ROS production is a key factor in the pathogenesis of Chronic Obstructive Pulmonary Disease (COPD), contributing to airway inflammation and tissue damage. Experimental studies, primarily in vitro and in animal models, have shown that apocynin can reduce oxidative stress and neutrophil infiltration in the lungs. For example, mouse models of COPD exposed to cigarette smoke have demonstrated reduced pulmonary inflammation and improved lung function upon treatment with apocynin (Han et al., 2010). However, clinical evidence in humans is currently lacking. There are no large-scale randomized controlled trials or established clinical guidelines endorsing apocynin for COPD treatment. The existing evidence is largely preclinical and mechanistic, suggesting potential benefit rather than proven efficacy. Therefore, while the scientific rationale exists and early research is promising, the overall level of evidence supporting the use of apocynin in COPD is low. More rigorous human studies are needed to determine its safety and therapeutic value in this context.

More about apocynin
More about Chronic Obstructive Pulmonary Disorder

Products containing apocynin

We currently have no products on Vitabase that contain this ingredient.